ZYNE — Zynerba Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall Cap

Annual balance sheet for Zynerba Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	59.8	70.1	59.2	67.8	50.6
Net Total Receivables	3.44	14.6	11.4	9.58	1.23
Prepaid Expenses
Total Other Current Assets
Total Current Assets	67	87.1	73.4	80.2	54.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.372	0.709	0.691	0.952	0.746
Other Long Term Assets
Total Assets	67.3	87.8	74.1	81.2	55.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.73	12.1	13.9	9.9	9.17
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.73	12.2	13.9	10.3	9.29
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	57.6	75.6	60.1	70.9	46.2
Total Liabilities & Shareholders' Equity	67.3	87.8	74.1	81.2	55.5
Total Common Shares Outstanding